Medicare Negotiation and Competitive Licensing Act of 2021
Latest action · Sep 8, 2021 Referred to the Subcommittee on Health.
Progress
Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.
- IntroducedJul 29, 2021
- Passed HouseNot reached
- Passed SenateNot reached
- To the PresidentNot reached
- Became lawNot reached
Summary
Medicare Negotiation and Competitive Licensing Act of 2021
This bill establishes several requirements relating to the prices of prescription drugs.
Specifically, the bill requires the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under Medicare. (Current law prohibits the CMS from doing so.) If the CMS is unable to negotiate the price of a drug, such drug is subject to competitive licensing in order to further its sale under health insurance programs, notwithstanding existing government-granted exclusivities.
The negotiated prices also apply to other federal health care programs, private health insurance, and the uninsured; pharmacies that charge more than the negotiated price for uninsured individuals are subject to civil penalties. Manufacturers must also comply with specified reporting requirements relating to prices and licensing, subject to civil penalties.
The bill also institutes an excise tax on drugs for which the price spikes beyond a certain limit, subject to specified exemptions, as well as on drugs for which the price exceeds the negotiated price.
Cosponsors 79
Members who signed on, in the order they did. Signatures ran from Jul 29, 2021 to Dec 14, 2022; 57 are original cosponsors, there from the day it was introduced.
| Seat | Cosponsor | Signed on | |
|---|---|---|---|
| D-NY | Adriano Espaillat | Original | Jul 29, 2021 |
| D-TX | Al Green | Original | Jul 29, 2021 |
| D-CA | Alan S. Lowenthal | Original | Jul 29, 2021 |
| D-NY | Alexandria Ocasio-Cortez | Original | Jul 29, 2021 |
| D-NJ | Andy Kim | Original | Jul 29, 2021 |
| D-MI | Andy Levin | Original | Jul 29, 2021 |
| D-MA | Ayanna Pressley | Original | Jul 29, 2021 |
| D-CA | Barbara Lee | Original | Jul 29, 2021 |
| D-MS | Bennie G. Thompson | Original | Jul 29, 2021 |
| D-CA | Brad Sherman | Original | Jul 29, 2021 |
| D-ME | Chellie Pingree | Original | Jul 29, 2021 |
| D-MO | Cori Bush | Original | Jul 29, 2021 |
| D-RI | David N. Cicilline | Original | Jul 29, 2021 |
| D-MI | Debbie Dingell | Original | Jul 29, 2021 |
| D-NV | Dina Titus | Original | Jul 29, 2021 |
Committees 5
Where it was sent and what each committee and subcommittee did with it, in order.
| Chamber | Committee | What it did |
|---|---|---|
| House | Energy and Commerce Committee | Referred Jul 29, 2021 |
| Health Subcommittee | Referred Jul 30, 2021 | |
| House | Ways and Means Committee | Referred Jul 29, 2021 |
| Health Subcommittee | Referred Jul 29, 2021 | |
| House | Oversight and Government Reform Committee | Referred Jul 29, 2021 |
| House | Veterans' Affairs Committee | Referred Jul 29, 2021 |
| Health Subcommittee | Referred Sep 8, 2021 | |
| House | Armed Services Committee | Referred Jul 29, 2021 |
Actions 5
Everything that happened, newest first.
- Sep 8, 2021Referred to the Subcommittee on Health.
- Jul 30, 2021Referred to the Subcommittee on Health.
- Jul 29, 2021Introduced in House
- Jul 29, 2021Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, Oversight and Reform, Veterans' Affairs, and Armed Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- Jul 29, 2021Referred to the Subcommittee on Health.
Research
What has been written about this bill: committee reports, cost estimates, the sponsor’s authority statement, printed hearings and the Congressional Research Service’s work.
Constitutional authority
The sponsor’s statement, as printed in the Congressional Record, vol. 167, no. 133, July 29, 2021, page H4294.
Titles 2
Every title it has carried, official and short, at each stage.
- Official Title as Introduced
- To amend title XVIII of the Social Security Act to require the Secretary of Health and Human Services to negotiate prices of drugs furnished under the Medicare program, and for other purposes.
- Short Title(s) as Introduced
- Medicare Negotiation and Competitive Licensing Act of 2021
Subjects
Assigned by the Library of Congress. Policy area: Health.
Text 1
Each version as it was printed, newest first.
- Jul 29, 2021Introduced in House
Support LegiList
This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.
Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.